human | Q5 |
P496 | ORCID iD | 0000-0002-1771-163X |
P3829 | Publons author ID | 2214976 |
P1053 | ResearcherID | N-6719-2016 |
P69 | educated at | The Chinese University of Hong Kong | Q15570 |
P108 | employer | Prince of Wales Hospital | Q4116367 |
The Chinese University of Hong Kong | Q15570 | ||
P735 | given name | Anthony | Q12241622 |
Anthony | Q12241622 | ||
P106 | occupation | researcher | Q1650915 |
P21 | sex or gender | male | Q6581097 |
Q89069464 | A Rare Cause of Ischemic Colitis |
Q53055029 | A pancreatic mass with multiple hepatic lesions. |
Q38375159 | A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma |
Q45003209 | A rare tumor of the common hepatic duct causing biliary obstruction |
Q49495478 | Advanced liver fibrosis but not steatosis is independently associated with albuminuria in Chinese patients with type 2 diabetes |
Q54373154 | An uncommon insertion mutation in exon 19 of EGFR showed stable disease after TKI treatment. |
Q38386410 | Applicability of BALAD score in prognostication of hepatitis B-related hepatocellular carcinoma. |
Q40511264 | Applicability of albumin-bilirubin-based Japan integrated staging score in hepatitis B-associated hepatocellular carcinoma |
Q48169110 | Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver disease |
Q52715384 | Assessment of programmed cell death ligand-1 expression by 4 diagnostic assays and its clinicopathological correlation in a large cohort of surgical resected non-small cell lung carcinoma. |
Q59313579 | Characterization of early IgA nephropathy |
Q33727871 | Characterization of rare transforming KRAS mutations in sporadic colorectal cancer. |
Q46176187 | Clinical factors associated with liver stiffness in hepatitis B e antigen-positive chronic hepatitis B patients. |
Q30392056 | Concurrent fatty liver increases risk of hepatocellular carcinoma among patients with chronic hepatitis B. |
Q42820412 | Detection of ALK rearrangement by immunohistochemistry in lung adenocarcinoma and the identification of a novel EML4-ALK variant. |
Q59203662 | Development of pre and post-operative models to predict early recurrence of hepatocellular carcinoma after surgical resection |
Q82648058 | Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease |
Q84484058 | Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years |
Q43139834 | Durability of peginterferon alfa-2b treatment at 5 years in patients with hepatitis B e antigen-positive chronic hepatitis B. |
Q100731921 | EBV-encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1 |
Q47259217 | EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma |
Q87182715 | EUS-guided alcohol injection of pancreatic neuroendocrine tumor |
Q57782079 | EXOSC4 functions as a potential oncogene in development and progression of colorectal cancer |
Q42220109 | Epstein-Barr virus-associated lymphoepithelioma-like cholangiocarcinoma: a rare variant of intrahepatic cholangiocarcinoma with favourable outcome. |
Q37005672 | Familial extrarenal Wilms tumor. |
Q84677306 | GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling |
Q46531274 | Genetic polymorphisms of adiponectin and tumor necrosis factor-alpha and nonalcoholic fatty liver disease in Chinese people |
Q92553855 | Genomic landscape of lymphoepithelioma-like hepatocellular carcinoma |
Q55491738 | Granulin epithelin precursor promotes colorectal carcinogenesis by activating MARK/ERK pathway. |
Q48308089 | Hepatoma-intrinsic CCRK inhibition diminishes myeloid-derived suppressor cell immunosuppression and enhances immune-checkpoint blockade efficacy. |
Q51054700 | High prevalence of colorectal neoplasm in patients with non-alcoholic steatohepatitis. |
Q39658315 | Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients |
Q87134638 | In vivo appearances of gallbladder carcinoma under magnifying endoscopy and probe-based confocal laser endomicroscopy after endosonographic gallbladder drainage |
Q48214198 | Incorporating albumin-bilirubin grade into the cancer of the liver Italian program system for hepatocellular carcinoma. |
Q51414931 | Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese. |
Q53469333 | Irreversible Electroporation of the Femoral Neurovascular Bundle: Imaging and Histologic Evaluation in a Swine Model. |
Q47857048 | Ketamine-related cholangiopathy: a retrospective study on clinical and imaging findings |
Q43682657 | Liver stiffness measurement by transient elastography as a predictor on posthepatectomy outcomes |
Q48127753 | Liver stiffness measurement predicts high-grade post-hepatectomy liver failure: A prospective cohort study. |
Q39013826 | MCM7 serves as a prognostic marker in diffuse-type gastric adenocarcinoma and siRNA-mediated knockdown suppresses its oncogenic function. |
Q52885993 | MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis. |
Q87915210 | MET DNA Alterations in NSCLC-Reply |
Q97087105 | Macromolecular proton fraction mapping based on spin-lock magnetic resonance imaging |
Q53223979 | Malignant pigmented clear cell epithelioid cell tumor (PEComa) in an adolescent boy with widespread metastases: a rare entity in this age group. |
Q39376558 | MiR-145 modulates multiple components of the insulin-like growth factor pathway in hepatocellular carcinoma |
Q41412869 | MiR-222 overexpression confers cell migratory advantages in hepatocellular carcinoma through enhancing AKT signaling. |
Q48218121 | New simple prognostic score for primary biliary cirrhosis: Albumin-bilirubin score |
Q35311036 | Non-Hodgkin's Lymphoma of the Knee: A Case Report |
Q42318989 | Primary hepatic gastrointestinal stromal tumor presented with rupture. |
Q54264125 | Profiling of Oncogenic Driver Events in Lung Adenocarcinoma Revealed MET Mutation as Independent Prognostic Factor. |
Q33594982 | Putative tumour-suppressor gene DAB2 is frequently down regulated by promoter hypermethylation in nasopharyngeal carcinoma |
Q90347922 | Quantifying and monitoring fibrosis in non-alcoholic fatty liver disease using dual-photon microscopy |
Q57782091 | RASAL2 promotes tumor progression through LATS2/YAP1 axis of hippo signaling pathway in colorectal cancer |
Q90254307 | Receptor tyrosine kinase fusions act as a significant alternative driver of the serrated pathway in colorectal cancer development |
Q43972620 | Renal outcome in type 2 diabetic patients with or without coexisting nondiabetic nephropathies |
Q89063458 | Repeating measurements by transient elastography in non-alcoholic fatty liver disease patients with high liver stiffness |
Q41073361 | Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study |
Q58029158 | Second-Trimester Detection of Mowat-Wilson Syndrome Using Comparative Genomic Hybridization Microarray Testing |
Q39551455 | Sirtuin 1 is upregulated in a subset of hepatocellular carcinomas where it is essential for telomere maintenance and tumor cell growth. |
Q39630002 | Steatotic hepatocellular carcinoma: a variant associated with metabolic factors and late tumour relapse |
Q48123565 | Systematic evaluation of circulating inflammatory markers for hepatocellular carcinoma |
Q39001820 | Targeting ribonucleotide reductase M2 subunit by small interfering RNA exerts anti-oncogenic effects in gastric adenocarcinoma. |
Q51093729 | The anti-diabetic drug exenatide, a glucagon-like peptide-1 receptor agonist, counteracts hepatocarcinogenesis through cAMP-PKA-EGFR-STAT3 axis. |
Q33779052 | Topical Application of Mesenchymal Stromal Cells Ameliorated Liver Parenchyma Damage After Ischemia-Reperfusion Injury in an Animal Model. |
Q46494735 | Transgenic cyclooxygenase-2 expression and high salt enhanced susceptibility to chemical-induced gastric cancer development in mice. |
Q51444679 | Validation of the NAFLD fibrosis score in a Chinese population with low prevalence of advanced fibrosis. |
Q38894603 | Wnt/β-Catenin activates MiR-183/96/182 expression in hepatocellular carcinoma that promotes cell invasion |
Q39586964 | Yes-associated protein 1 exhibits oncogenic property in gastric cancer and its nuclear accumulation associates with poor prognosis. |
Q28383997 | Yin Yang 1 contributes to gastric carcinogenesis and its nuclear expression correlates with shorter survival in patients with early stage gastric adenocarcinoma |
Q48171440 | miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis |
Search more.